Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions

American Journal of Cardiology

Volumn 94, Issue 1, 2004, Pages 30-34

  Gurm, Hitinder S ^b   Lincoff, A Michael ^a   Kleiman, Neil S ^b   Kereiakes, Dean J ^b   Tcheng, James E ^b   Aronow, Herbert D ^b   Askari, Arman T ^b   Brennan, Danielle M ^b   Topol, Eric J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEPARIN;

ANEMIA; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; FEMALE; GLOMERULUS FILTRATION RATE; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CANADA; FEMALE; GLOMERULAR FILTRATION RATE; HEMATOCRIT; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 3042662166     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.03.025     Document Type: Article

References (20)

1. Astor B.C., Muntner P., Levin A., Eustace J.A., Coresh J. Association of kidney function with anemia the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 162:2002;1401-1408
2. Gurm H.S., Gupta R., Lauer M.S., Raymond R., Ellis S.G. Hemoglobin level is an independent predictor of mortality in patients undergoing percutaneous coronary artery interventions (abstr). J Am Coll Cardiol. 41:2003;1005. A-213
3. Al-Ahmad A., Rand W.M., Manjunath G., Konstam M.A., Salem D.N., Levey A.S., Sarnak M.J. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 38:2001;955-962
4. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med. 330:1994;956-961
5. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696
6. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet. 352:1998;87-92
7. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 130:1999;461-470
8. Landefeld C.S., Cook E.F., Flatley M., Weisberg M., Goldman L. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med. 82:1987;703-713
9. Ting H.H., Tahirkheli N.K., Berger P.B., McCarthy J.T., Timimi F.K., Mathew V., Rihal C.S., Hasdai D., Holmes D.R. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol. 87:2001;630-633
10. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 39:2002;1113-1119
11. Rubenstein M.H., Sheynberg B.V., Harrell L.C., Schunkert H., Bazari H., Palacios I.F. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol. 87:2001;856-860
12. Rubenstein M.H., Harrell L.C., Sheynberg B.V., Schunkert H., Bazari H., Palacios I.F. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation. 102:2000;2966-2972
13. Gruberg L., Dangas G., Mehran R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Lansky A.J., Stone G.W., Leon M.B. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 55:2002;66-72
14. Kronenberg F., Konig P., Neyer U., Auinger M., Pribasnig A., Lang U., Reitinger J., Pinter G., Utermann G., Dieplinger H. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 6:1995;110-120
15. Keane W.F., Collins A.J. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis. 24:1994;1010-1018
16. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003:105-110
17. Coresh J., Longenecker J.C., Miller E.R. III, Young H.J., Klag M.J. Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol. 9:1998;S24-S30
18. Kosiborod M., Smith G.L., Radford M.J., Foody J.M., Krumholz H.M. The prognostic importance of anemia in patients with heart failure. Am J Med. 114:2003;112-119
19. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 39:2002;1780-1786
20. Al-Ahmad A., Rand W.M., Manjunath G., Konstam M.A., Salem D.N., Levey A.S., Sarnak M.J. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 38:2001;955-962